SallyJohnson United KingdomNational Renal Complement Therapeutics Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, United Kingdom

Dr Sally Johnson is the lead paediatric clinician at the UK National Renal Complement Therapeutics Centre, which has a national role in the management of patients with atypical HUS and C3G. She is also a paediatric nephrologist at the Great North Children’s Hospital, UK. She undertook clinical and academic training in the West Midlands, including a PhD in aHUS. She was Chief Investigator of The National Study of MPGN and C3G and of the ECUSTEC trial, a randomised controlled trial of Eculizumab in STEC-HUS. She was Research Secretary for the British Association for Paediatric Nephrology (BAPN) from 2019 to 2022 and is co-chair of the BAPN Clinical Studies Group. She is a member of the Kidney Research UK (KRUK) grants committee.